The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Mikko Niemi

Department of Clinical Pharmacology

University of Helsinki and Helsinki University Central Hospital




Name/email consistency: high



  • Department of Clinical Pharmacology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. 2002 - 2007


  1. Role of OATP transporters in the disposition of drugs. Niemi, M. Pharmacogenomics (2007) [Pubmed]
  2. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Niemi, M., Arnold, K.A., Backman, J.T., Pasanen, M.K., Gödtel-Armbrust, U., Wojnowski, L., Zanger, U.M., Neuvonen, P.J., Eichelbaum, M., Kivistö, K.T., Lang, T. Pharmacogenet. Genomics (2006) [Pubmed]
  3. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide. Niemi, M., Tornio, A., Pasanen, M.K., Fredrikson, H., Neuvonen, P.J., Backman, J.T. Eur. J. Clin. Pharmacol. (2006) [Pubmed]
  4. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin. Niemi, M., Pasanen, M.K., Neuvonen, P.J. Clin. Pharmacol. Ther. (2006) [Pubmed]
  5. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Niemi, M., Backman, J.T., Kajosaari, L.I., Leathart, J.B., Neuvonen, M., Daly, A.K., Eichelbaum, M., Kivistö, K.T., Neuvonen, P.J. Clin. Pharmacol. Ther. (2005) [Pubmed]
  6. Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide. Niemi, M., Backman, J.T., Juntti-Patinen, L., Neuvonen, M., Neuvonen, P.J. Br. J. Clin. Pharmacol (2005) [Pubmed]
  7. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes. Niemi, M., Cascorbi, I., Timm, R., Kroemer, H.K., Neuvonen, P.J., Kivistö, K.T. Clin. Pharmacol. Ther. (2002) [Pubmed]
WikiGenes - Universities